CENTRAL NERVOUS SYSTEM DISEASES
Clinical trials for CENTRAL NERVOUS SYSTEM DISEASES explained in plain language.
Never miss a new study
Get alerted when new CENTRAL NERVOUS SYSTEM DISEASES trials appear
Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets brain inflammation to slow Alzheimer's
Disease control CompletedThis study tested an experimental drug called XPro1595 in 208 people with early Alzheimer's disease who also had signs of brain inflammation. The goal was to see if the drug could improve memory, thinking, and daily function compared to a placebo over 24 weeks. Researchers also c…
Matched conditions: CENTRAL NERVOUS SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New device aims to pull clots from the brain in major strokes
Disease control CompletedThis completed study tested a new device called the Supernova stent retriever in 55 people with severe stroke caused by a large blood clot in the brain. The device is threaded through blood vessels to grab and remove the clot, restoring blood flow. Researchers measured how often …
Matched conditions: CENTRAL NERVOUS SYSTEM DISEASES
Phase: NA • Sponsor: Gravity Medical Technology, INC • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Friends and family may be key to preventing second strokes
Disease control CompletedThis study tested whether using social networks (like family and friends) can help people at high risk for stroke stick to their medications and control risk factors after leaving the hospital. Researchers enrolled 720 patients and compared standard care with a social network-bas…
Matched conditions: CENTRAL NERVOUS SYSTEM DISEASES
Phase: NA • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Safer MRI scans for infants? new contrast agent studied in toddlers
Diagnosis CompletedThis study tested a contrast agent called gadopiclenol in 36 infants under 2 years old who needed an MRI. The goal was to see how the drug behaves in their bodies and check for safety. The children received a single injection before their MRI, and researchers measured drug levels…
Matched conditions: CENTRAL NERVOUS SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Guerbet • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC